Companies
If you would like to subscribe to Western Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Western Europe Pharma & Healthcare Insight please click on the trial link below.
Will Private Equity Target The Drug Industry?
March 2007 | Industry NewsSorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Western Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Western Europe Pharma & Healthcare Insight please click on the trial link below.
With the news of Setafno Pessina's recent approach for UK-based retailer and pharmacy chain Alliance Boots , backed by US-based buy-out specialist Kohlberg Kravis Roberts , there is speculation that private equity firms could be looking to target the pharmaceutical industry. Other industries have already seen a high degree of involvement from private equity firms, which snap up publicly-quoted companies and restructure them before selling them on at a profit.